LINCOLN, NEBRASKA (RFD NEWS) — A new vaccine is showing promise in combating Highly Pathogenic Avian Influenza (HPAI), with testing currently underway in mice and dairy calves. The promising research is led by the University of Nebraska–Lincoln (UNL).
UNL Professor of Biological Sciences Eric Weaver joined us on Tuesday’s Market Day Report to provide an update on the development.
In his interview with RFD News, Weaver discussed details of the vaccine and the results from early testing. He also outlined the next steps in the research process as work continues.
Finally, Weaver explained the potential impacts this vaccine could have on the livestock industry as it continues to battle HPAI.
Related Stories
AFBF Economist Bearnt Nelson joins us with insights into current turkey flock sizes, HPAI concerns, and production impacts on holiday demand.
Farmers may benefit from higher turkey prices this holiday season, but risks from HPAI and limited poult placements could further strain the supply.
Disease risks remain a key factor to watch heading into fall.
Wholesale egg prices decreased by 64% from their peak in late 2024, while retail prices have dropped by 27%, according to a recent USDA update.
